• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVyera Pharmaceuticals

Vyera Pharmaceuticals

Page 2 of 4
APTOPIX Shkreli Arrest
FinanceKaloBios Just Fired Martin Shkreli as CEO
By Laura LorenzettiDecember 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli Says This Is the Real Reason He Was Arrested
By Michal AddadyDecember 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli’s Twitter Account Hacked
By Reuters and Aaron TaskDecember 20, 2015
Martin Shkreli arrested
HealthMartin Shkreli’s Arrest Halts Leukemia Drug Trial
By Michal AddadyDecember 20, 2015
Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’
LeadershipMartin Shkreli Says Securities Fraud Charges Are ‘Baseless’
By ReutersDecember 19, 2015
US-CRIME-JUSTICE-SHKRELI
HealthTuring Replaces Martin Shkreli with Interim CEO
By Laura LorenzettiDecember 18, 2015
US-CRIME-JUSTICE-SHKRELI
HealthMartin Shkreli Is Reportedly Stepping Down as Turing CEO
By Benjamin SnyderDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
FinanceWhat’s Going to Happen to Martin Shkreli’s $2 Million Wu-Tang Album?
By ReutersDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
FinanceAccused Pharma CEO Martin Shkreli: ‘My Investors Made Lots Of Money’
By Jen WiecznerDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
FinanceHow Martin Shkreli Allegedly Created a ‘Ponzi Scheme’ With Biotech Stocks
By Jen WiecznerDecember 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceCongressman Calls Out Valeant’s ‘Lack of Transparency’
By Laura LorenzettiDecember 16, 2015
MSMB Capital Management CIO Martin Shkreli
HealthInfamous Pharma CEO Martin Shkreli Paid $2 Million for a Wu-Tang Album
By Daniel RobertsDecember 9, 2015
MSMB Capital Management CIO Martin Shkreli
HealthExpress Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike
By Claire GrodenDecember 1, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Offers Hospitals Discounts on Daraprim Price
By Laura LorenzettiNovember 25, 2015
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO Blasts Company that Raised Drug Prices 5,000%
By Laura LorenzettiNovember 20, 2015
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
AI
Thousands of CEOs admit AI had no impact on employment or productivity—and it has economists resurrecting a paradox from 40 years agoplaceholder alt text
By Sasha RogelbergApril 19, 2026
Energy
Markets shudder as Strait of Hormuz starts resembling a combat zone. 'We're prepared to subject you to disabling fire'placeholder alt text
By Jason MaApril 19, 2026
Economy
The explosion of U.S. debt is wiping out the 'safety premium' of Treasury bonds, and time is running out for an orderly fiscal solution, IMF warnsplaceholder alt text
By Jason MaApril 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.